Official Twitter account for the American Association of Clinical Endocrinology (AACE). Elevating endocrinology since 1991. Retweets ≠ endorsements.
Jacksonville, FL
- Tweets 10,719
- Following 1,749
- Followers 16,851
- Likes 5,207
Complimentary webinar on October 2 at 1 PM EDT: Improving Recognition, Diagnosis, and Management of Post-Bariatric Hypoglycemia. Tackle post-bariatric hypoglycemia & congenital hyperinsulinism. Learn to:
• Spot diagnostic pitfalls & GLP-1–mediated mechanisms
• Assess real-world hypoglycemia burden
• Build individualized, evidence-based treatment plans
Register now 👉 pro.aace.com/education-and-e…
#WeAreAACE
4
4
551
Join endocrine expert and Endocrine Practice Associate Editor, Dr. Cecilia M. Lansang as she interviews Emory’s Dr. Guillermo Umpierrez on his journey in medicine, endocrinology, and inpatient diabetes care. He reflects on his DKA and ketosis-prone diabetes research, the mentors who guided him, and the importance of passion, environment, and celebrating small wins. Listen here: pro.aace.com/podcast/episode…
@vtangpricha
3
9
617
This study demonstrates that both basal insulin reduction and carbohydrate snack strategies are effective for managing post-exercise glycemic control in type 1 diabetes, with basal insulin reduction offering an advantage in delaying hypoglycemia onset. Read more: endocrinepractice.org/articl…
@vtangpricha
459
Looking for a patient-friendly resource on Cushing’s syndrome symptoms, complications, treatment options, and more? Check out the AACE Patient Guide on Cushing’s Syndrome at
aace.com/disease-and-conditi… and equip your patients with clear, expert-vetted, easy-to-understand guidance today.
1
362
KPDM exemplifies diabetes heterogeneity and is a common presentation of DKA, particularly among obese Black and Hispanic adults. Early recognition and individualized therapy optimize β-cell recovery, prolong near-normoglycemic remission, and improve outcomes. Read more: endocrinepractice.org/articl…
@vtangpricha
1
1
479
AACE retweeted
Dyslipidemia management is an important part of comprehensive diabetes care and cardiovascular risk reduction.
Dyslipidemia is a major driver of cardiovascular risk in patients with type 2 diabetes (T2D), and lipid management is a key component of the the latest AACE Consensus Statement: Algorithm for Management of Adults with Type 2 Diabetes - 2026 Update. Immediate Past President Scott D. Isaacs, MD, FACP, FACE, reviews new recommendations on LDL-C goals and individualized care in this population. Listen to the podcast at reachmd.com/programs/heart-m….
#WeAreAACE
2
6
1,172
Early detection and treatment of cystic fibrosis–related diabetes improves pulmonary outcomes and survival. Identifying screening strategies beyond the oral glucose tolerance test may improve detection, intervention, and outcomes. Read more: endocrinepractice.org/articl…
@vtangpricha
1
7
659
Patients often have questions about obesity, and AACE provides accurate answers and resources. The AACE Journey for Patients With Obesity now includes a new informational video, infographic, and interactive quiz. Direct patients to aace.com/patient-journey/obe… to access these resources and take the next step in their health journey.
1
418
Happening today at 4 PM EDT! Free live webinar with @DrAuchus on non-21-OHD classic #CAH—diagnosis, genetics & individualized treatment tips.
Don’t miss out: 👉 pro.aace.com/classic-cah-bey…
#WeAreAACE
468
Tomorrow 4 PM EDT: Join Dr. Richard Auchus for a FREE live webinar on #CAH beyond 21-OHD. Learn about unique genetic defects, diagnostic tests & personalized care strategies.
Register 👉 [link]pro.aace.com/classic-cah-bey…
#WeAreAACE
5
539
Our Health Care Advocacy Webinar Series is now available as a free, 4-part on-demand program designed for endocrinologists and health care professionals.
Strengthen your voice in health care advocacy with expert-led insights on driving impact at the institutional, state, and national levels. This series explores emerging issues, including AI, team-based care, and telemedicine, and features live Q&A discussions with AACE experts.
Learn more: pro.aace.com/advocacy/aace-h….
1
1
407
Osteoporosis treatment choice may influence future diabetes risk. IV bisphosphonates appear particularly beneficial for patients at high diabetes risk and may support individualized therapy decisions. Read more: endocrinepractice.org/articl…
@vtangpricha
1
5
544
Dyslipidemia is a major driver of cardiovascular risk in patients with type 2 diabetes (T2D), and lipid management is a key component of the the latest AACE Consensus Statement: Algorithm for Management of Adults with Type 2 Diabetes - 2026 Update. Immediate Past President Scott D. Isaacs, MD, FACP, FACE, reviews new recommendations on LDL-C goals and individualized care in this population. Listen to the podcast at reachmd.com/programs/heart-m….
#WeAreAACE
2
6
1,499
Our webinar, Transforming Patient Care with the Obesity Algorithm: Practical Insights is now available as a complimentary on-demand webinar designed to equip health care professionals with practical, evidence-based strategies for the effective management of obesity as a serious, progressive chronic disease.
Explore the importance of proactive screening, accurate staging, and long-term treatment to prevent complications and address obesity-related comorbidities.
Register today: pro.aace.com/education-and-e….
3
498
With obesity affecting an estimated 90 million people in the United States, GLP-1 receptor agonists have emerged as highly effective pharmacologic interventions for obesity and related cardiometabolic comorbidities. These and other obesity pharmacotherapies become increasingly prescribed, clinicians need practical, evidence-based tools to guide nutritional counseling. Dietary quality becomes especially critical when caloric intake is reduced — nutritional needs must still be fully met. Read more and download our quick-reference clinician guide: pro.aace.com/nutritional-con…
4
615
This study demonstrates that both basal insulin reduction and carbohydrate snack strategies are effective for managing post-exercise glycemic control in type 1 diabetes, with basal insulin reduction offering an advantage in delaying hypoglycemia onset. Read more: endocrinepractice.org/articl…
@vtangpricha
7
15
822
Join endocrinologist Elizabeth Bauer, MD, FACP, FACE, DABOM, as she speaks with Michelle about her experience living with obesity, including the challenges, stigma, and turning points that shaped her path. Together, they explore the AACE Journey for Patients With Obesity, as Michelle shares which parts she found most helpful for understanding obesity as a chronic disease and navigating next steps. Don’t miss this inspiring discussion, brought to you with the support of Boehringer-Ingelheim, Lilly, Novo Nordisk, and Amgen.
piped.video/watch?v=LHg2CdM6…
2
588
When could AI become part of the standard of care—and is FDA authorization enough? Steven Petak, MD, JD, and Johnson Thomas, MD, discuss evidence, validation, liability, and patient disclosure in endocrine care. Watch: aaceendocrine.ai/videos/roun…
@JohnsonThomasMD
1
2
553
Patients whose blood sugar is 240 mg/dL or higher should check for ketones every 4-6 hours, as high levels can be an early sign of diabetic ketoacidosis (DKA). Point your patients with diabetes to aace.com/patient-journey/dia…, the AACE Patient Journey of Diabetes Technology for details on ketone tests and much more.
1
4
516
Are you prepared to manage your diabetes in an emergency? While emergency situations are stressful and challenging for anyone, they can be potentially life-threatening to a person with a chronic medical disease such as diabetes.
Our Diabetes Emergency Plan is a convenient checklist that contains all of the essential items those with diabetes need to have readily available in the event of an emergency: aace.com/disease-and-conditi….
1
445